Illustration of a heart on the navy background with hash pattern overlay

Impella CP®

with SmartAssist® Heart Pump
Percutaneous insertion, increased flow and intelligent patient management
 

Stabilize. Unload. Recover.

New dimensions for your patient management

Learn more about the next generation of heart recovery and profit from its many advantages in the field of patient management.

  • Reduce potential complications with the help of the single-access approach and a new design of our dilators.
  • Impella CP with SmartAssist is approved for percutaneous and axillary access and offers a wide range of applications.
  • The SmartAssist platform offers you with Impella Connect the remote monitoring of your patients 24/7.

Reimbursement Support

Abiomed is engaged in creating the necessary evidence and demonstrating the clinical and economic value of our product portfolio to hospital trusts and commissioners alike. Should you require any support on identifying and leveraging funding opportunities for services including any of our products please contact us at uk_reimbursement@abiomed.com.

2021

New Insertion Techniques for a better Clinical Outcome

  • Use of single-access approach
  • New tapered dilator 
2019

Improve Clinical Outcomes using the SmartAssist Platform

  • Remote support with Impella Connect
  • Advanced Metrics on the AIC
  • Assists with positioning, management, and weaning
2017

Increase User Experience by:

  • Improved 14F Peel Away Sheaths
  • Improved Position Stability & Ease of Use
  • Purge Wizards & higher flow in the Cath Lab
2016

Faster Set-up and Faster Case Start through Step by Step Instructions on the AIC

2014

Improved Hemodynamic Support through Increased Positional Stability

Designed to Improve Patient Outcomes

Technical Overview

The Impella CP with SmartAssist heart pump allows for sustained peak flows of up to 4.3 L/min (>85% of a normal cardiac cycle). It is designed to improve patient outcomes by using real-time intelligence to optimize positioning, managing and weaning of Impella® pump.

  • Safe positioning: New sensors support the handling and positioning of the Impella CP
  • Pressure detection in the aorta by means of an optical sensor
  • Microaxial motor detects pressure difference between aorta and left ventricle

Download Additional Resources

Download the product brochure.

Download

Download the step-by-step guide.

Download

Download the data sheet.

Download

Download the step-by-step guide.

Download
Two hands holding a smartphone with Impella Connect

Secure, cloud-based, remote monitoring of Impella® devices' status for better patient outcomes

Indication and Safety Information EU

INDICATIONS FOR USE EU

The Impella CP with SmartAssist® (intracardiac pump for supporting the left ventricle) is intended for clinical use in cardiology and in cardiac surgery for up to 5 days for the following indications, as well as others:
· The Impella is a circulatory support system for patients with reduced left ventricular function, e.g., post-cardiotomy, low output syndrome, cardiogenic shock after acute myocardial infarction, or for myocardial protection after acute myocardial infarction
· The Impella may also be used as a cardiovascular support system during coronary bypass surgery on the beating heart, particularly in patients with limited preoperative ejection fraction with a high risk of postoperative
low output syndrome.
· Support during high risk percutaneous coronary intervention (PCI)
· Post PCI

CONTRAINDICATIONS EU

· Mechanical aortic valves, severe aortic valvular stenosis or valvular regurgitation
· Hematological disorder causing fragility of the blood cells or hemolysis
· Hypertrophic obstructive cardiomyopathy (HOCM)
· Aneurysm or necrotomy or severe anomaly of the ascending aorta and / or the aortic arch
· Mural thrombus in the left ventricle
· Ventricular septal defect (VSD) after myocardial infarction
· Anatomic conditions precluding insertion of the pump
· Other illnesses or therapy requirements precluding use of the pump
· Severe peripheral arterial occlusion disease (PAOD) is a relative contraindication

POSSIBLE COMPLICATIONS EU

There are risks of complications with every procedure using a blood pump. These include among others:
Dazu gehören u. a.:
· Hemolysis
· Bleeding
· Immune reaction
· Embolism, thrombosis
· Vascular injury through to angionecrotomy
· Positioning problems
· Infection and septicemia
· Dislocation of the pump
· Cardiovalvular injuries due to extreme movement of the suction cannula in relation to the cardiac valve or
as a result of attachment by suction of the pump to the valve system following incorrect positioning
· Endocardiac injuries as a result of attachment of the pump due to suction
· Pump failure, loss of pump components following a defect
· Patient dependency on the pump after use for support
In addition to the risks above, there are other WARNINGS and PRECAUTIONS associated with Impella devices.
For more information please see the Instructions for Use Manuals.

IMP-3059